News | July 17, 2025
Corona Remedies acquires 7 brands from Bayer's pharma division in India
This marks the fourth acquisition by Corona Remedies from multinational corporations
This marks the fourth acquisition by Corona Remedies from multinational corporations
The company received seven observations in the Form-483
Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thoracic cancers for two first-in-class ADCs
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
The company is confident of addressing all the observations within the stipulated time
Subscribe To Our Newsletter & Stay Updated
